相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early liver metastases after failure of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?
Thomas Boerner et al.
HPB (2021)
Perioperative Chemotherapy for Resectable Liver Metastases in Colorectal Cancer: Do We Have a Blind Spot?
Christopher M. Booth et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Colon Cancer, Version 2.2021
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial
Yukihide Kanemitsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
A randomized phase II/III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver metastasis from colorectal cancer: JCOG0603 study.
Yukihide Kanemitsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis
Wei Liu et al.
ONCOTARGET (2016)
The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator
N. Ayez et al.
EJSO (2015)
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials
Hans-Joachim Schmoll et al.
LANCET ONCOLOGY (2014)
Effect of Neoadjuvant Chemotherapy in Patients with Resectable Colorectal Liver Metastases
Dexiang Zhu et al.
PLOS ONE (2014)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
FOLFIRI plus bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of published trials
Giordano Domenico Beretta et al.
MEDICAL ONCOLOGY (2013)
Progression while Receiving Preoperative Chemotherapy Should Not Be an Absolute Contraindication to Liver Resection for Colorectal Metastases
Luca Vigano et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
EPIC:: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
Alberto F. Sobrero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Actual 10-year survival after resection of colorectal liver Metastases defines cure
James S. Tomlinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Epidemiology and management of liver metastases from colorectal cancer
Sylvain Manfredi et al.
ANNALS OF SURGERY (2006)
Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases?
R Adam et al.
ANNALS OF SURGERY (2004)
分享论文
